Robenacoxib versus meloxicam for the management of pain and inflammation associated with soft tissue surgery in dogs: a randomized, non-inferiority clinical trial

por Gruet, Philippe, Seewald, Wolfgang, King, Jonathan N
Publicado 2013

Evaluation of injectable robenacoxib for the treatment of post-operative pain in cats: results of a randomized, masked, placebo-controlled clinical trial

por King, Stephen, Roberts, Elizabeth S., King, Jonathan N.
Publicado 2016

Evaluation of Oral Robenacoxib for the Treatment of Postoperative Pain and Inflammation in Cats: Results of a Randomized Clinical Trial

por King, Stephen, Roberts, Elizabeth S., Roycroft, Linda M., King, Jonathan N.
Publicado 2012

Robenacoxib versus meloxicam for the control of peri-operative pain and inflammation associated with orthopaedic surgery in cats: a randomised clinical trial

por Speranza, Cindy, Schmid, Vincent, Giraudel, Jerome M, Seewald, Wolfgang, King, Jonathan N
Publicado 2015

Efficacy and safety of oral robenacoxib (tablet) for the treatment of pain associated with soft tissue surgery in client-owned dogs

por Friton, Gabriele, Thompson, Caryn Marie, Karadzovska, Daniela, King, Stephen, King, Jonathan N.
Publicado 2017

Effect of benazepril, robenacoxib and their combination on glomerular filtration rate in cats

por King, Jonathan N., Panteri, Alessandro, Graille, Melanie, Seewald, Wolfgang, Friton, Gabriele, Desevaux, Cyril
Publicado 2016

Efficacy, acceptability and tolerability of the new oral phosphate binder Lenziaren® in healthy cats fed a standard diet

por King, Jonathan N, Erasmus, Heidi L, Delport, Peet C, Bester, Ina CJ, Seewald, Wolfgang
Publicado 2014

Evaluation of a fixed-dose combination of benazepril and pimobendan in dogs with congestive heart failure: a randomized non-inferiority clinical trial

por King, Jonathan N., Hirakawa, Atsushi, Sonobe, Junko, Otaki, Hiroshi, Sakakibara, Nobuhiro, Seewald, Wolfgang, Forster, Sophie
Publicado 2018

Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib

por Lees, Peter, Toutain, Pierre‐Louis, Elliott, Jonathan, Giraudel, Jerome M., Pelligand, Ludovic, King, Jonathan N.
Publicado 2022

Clinical safety of robenacoxib in cats with chronic musculoskeletal disease

por King, Jonathan N., Seewald, Wolfgang, Forster, Sophie, Friton, Gabriele, Adrian, Derek E., Lascelles, B. Duncan X.
Publicado 2021

Robenacoxib shows efficacy for the treatment of chronic degenerative joint disease-associated pain in cats: a randomized and blinded pilot clinical trial

por Adrian, Derek, King, Jonathan N., Parrish, Rudolph S., King, Stephen B., C. Budsberg, Steven, Gruen, Margaret E., Lascelles, B. Duncan X.
Publicado 2021

Evaluation of benazepril in cats with heart disease in a prospective, randomized, blinded, placebo‐controlled clinical trial

por King, Jonathan N., Martin, Mike, Chetboul, Valérie, Ferasin, Luca, French, Anne T., Strehlau, Günther, Seewald, Wolfgang, Smith, Sarah G. W., Swift, Simon T., Roberts, Susan L., Harvey, Andrea M., Little, Christopher J. L., Caney, Sarah M. A., Simpson, Kerry E., Sparkes, Andrew H., Mardell, Eleanor J., Bomassi, Eric, Muller, Claude, Sauvage, John P., Diquélou, Armelle, Schneider, Matthias A., Brown, Laurence J., Clarke, David D., Rousselot, Jean‐Francois
Publicado 2019